Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Tax Provisions (2019 - 2025)

CorMedix (CRMD) has disclosed Tax Provisions for 7 consecutive years, with $42.4 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 18446315.22% to $42.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$13.0 million through Dec 2025, down 834.71% year-over-year, with the annual reading at -$13.0 million for FY2025, 834.7% down from the prior year.
  • Tax Provisions hit $42.4 million in Q4 2025 for CorMedix, up from -$56.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $42.4 million in Q4 2025 to a low of -$56.0 million in Q3 2025.
  • Historically, Tax Provisions has averaged -$1.8 million across 4 years, with a median of -$292923.5 in 2022.
  • Biggest five-year swings in Tax Provisions: tumbled 71.16% in 2021 and later surged 18446315.22% in 2025.
  • Year by year, Tax Provisions stood at $1.9 million in 2021, then plummeted by 131.21% to -$585617.0 in 2022, then skyrocketed by 99.96% to -$230.0 in 2024, then soared by 18446315.22% to $42.4 million in 2025.
  • Business Quant data shows Tax Provisions for CRMD at $42.4 million in Q4 2025, -$56.0 million in Q3 2025, and $521507.0 in Q2 2025.